Functional interaction of the HTLV-1 transactivator Tax with activating transcription factor-4 (ATF4)

Oncogene
T R ReddyF Wong-Staal

Abstract

The Tax protein of the Human T-cell Leukemia Virus (HTLV) activates the expression of viral mRNA through a three 21 bp repeat enhancer located within the HTLV-1 LTR. Since Tax does not bind to the 21 bp DNA repeats directly, it has been speculated that Tax interacts with cellular protein(s) which mediate binding to the enhancer. We employed the yeast two hybrid system to identify host proteins that are potentially relevant to Tax transactivation. We identified a Tax binding protein encoded from a cDNA expression library derived from peripheral blood lymphocytes. The corresponding cDNA has sequence identity with a known transcription factor, activating factor-4 (ATF-4). ATF-4 also binds to GST-Tax fusion protein in vitro. Tax mutants that did not transactivate the HTLV-1 LTR also failed to bind ATF-4. The critical domain for Tax binding resides in a 85 amino acid stretch in the C-terminus of ATF-4, which contains the basic domain and leucine zipper. We further demonstrated that both full length and N-terminal truncated ATF-4 were able to enhance Tax transactivation. Thus, ATF-4 may act as an adapter between Tax and the TRE (Tax responsive element), and play an important role in Tax-mediated transactivation.

Citations

Mar 23, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Kristine P Malabanan, Levon M Khachigian
May 17, 2003·Experimental Cell Research·Daima Ord, Tõnis Ord
Oct 27, 1999·European Journal of Cell Biology·G CibelliG Thiel
Apr 6, 2001·Neurochemistry International·S SchochG Thiel
Oct 6, 1999·Molecular and Cellular Endocrinology·Y KatoT Kato
Sep 13, 2005·Oncogene·Fatah Kashanchi, John N Brady
Nov 5, 2011·AIDS Research and Human Retroviruses·Elisabetta CaselliDario Di Luca
Sep 22, 2006·Journal of Virology·Morgan HakkiAdam P Geballe
Mar 10, 2001·Molecular and Cellular Biology·I LassotF Margottin-Goguet
Aug 3, 2004·Retrovirology·Cynthia de la Fuente, Fatah Kashanchi
Aug 18, 2004·Retrovirology·Inbal AzranMordechai Aboud
Aug 16, 2008·Retrovirology·Mathieu BoxusLuc Willems
Jan 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·T R ReddyF Wong-Staal
Sep 29, 2011·Experimental Cell Research·Yusuke HiwatashiKen-ichi Yasumoto
Apr 21, 2001·Molecular and Cellular Neurosciences·E VernonJ M Henley
Oct 21, 2000·Virology·V PietiäinenT Hyypiä
Jan 29, 2005·The Journal of Biological Chemistry·Xubin ZhouXueliang Zhu
Sep 16, 2016·EMBO Reports·Karolina Pakos-ZebruckaAdrienne M Gorman
Nov 24, 1999·The Journal of Biological Chemistry·A L Kimzey, W S Dynan
Apr 5, 2000·The Journal of Biological Chemistry·C WestbergF Wong-Staal

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.